Education
About Us
Working with TipRanks
Follow Us
Curevac N.V. (CVAC)
:CVAC
CVAC Stock Chart & Stats
$5.36
-$0.57(-12.18%)
At close: 4:00 PM EST
$5.36
-$0.57(-12.18%)
Day’s Range― - ―
52-Week Range$2.37 - $5.72
Previous CloseN/A
Volume1.54M
Average Volume (3M)498.55K
Market Cap
$1.17B
Enterprise ValueN/A
Total Cash (Recent Filing)$395.81M
Total Debt (Recent Filing)$36.03M
Price to Earnings (P/E)5.7
Beta1.15
Next Earnings
Nov 18, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding225,181,640
10 Day Avg. Volume660,018
30 Day Avg. Volume498,550
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.06
Price to Sales (P/S)1.38
P/FCF Ratio8.86
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AcquisitionBNTX announced an all-stock acquisition offer for CVAC for ~$1.25B, with CVAC shares exchanged for $5.46 in BNTX ADS – a ~55% premium to CVAC’s trailing 3-month average price.
Financial PositionCVAC ended the period with €392.7mm in cash and equivalents, expected to fund operations into 2028.
Bears Say
Market UncertaintyThere is uncertainty in the respiratory vaccine franchise, partnered with GSK, as the COVID market wanes.
Operating LossOperating loss of €61.7mm was above consensus expectations.
CureVac News
CVAC FAQ
What was Curevac N.V.’s price range in the past 12 months?
Curevac N.V. lowest stock price was $2.37 and its highest was $5.72 in the past 12 months.
What is Curevac N.V.’s market cap?
Curevac N.V.’s market cap is $1.17B.
When is Curevac N.V.’s upcoming earnings report date?
Curevac N.V.’s upcoming earnings report date is Nov 18, 2025 which is in 9 days.
How were Curevac N.V.’s earnings last quarter?
Curevac N.V. released its earnings results on Aug 15, 2025. The company reported -$0.243 earnings per share for the quarter, missing the consensus estimate of -$0.211 by -$0.032.
Is Curevac N.V. overvalued?
According to Wall Street analysts Curevac N.V.’s price is currently Overvalued.
Does Curevac N.V. pay dividends?
Curevac N.V. does not currently pay dividends.
What is Curevac N.V.’s EPS estimate?
Curevac N.V.’s EPS estimate is -0.08.
How many shares outstanding does Curevac N.V. have?
Curevac N.V. has 225,181,640 shares outstanding.
What happened to Curevac N.V.’s price movement after its last earnings report?
Curevac N.V. reported an EPS of -$0.243 in its last earnings report, missing expectations of -$0.211. Following the earnings report the stock price went down -0.544%.
Which hedge fund is a major shareholder of Curevac N.V.?
Currently, no hedge funds are holding shares in CVAC
CureVac Stock Smart Score
Company Description
Curevac N.V.
CureVac (CVAC) is a biopharmaceutical company that specializes in the development of mRNA-based therapies and vaccines. Founded in Germany, the company aims to harness the power of messenger RNA to treat various diseases, including infectious diseases, cancer, and rare diseases. CureVac is at the forefront of the mRNA technology sector, focusing on creating innovative solutions that can potentially transform the landscape of medicine and immunotherapy.
CVAC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Syndax Pharmaceuticals
―
Stoke Therapeutics
―
Enliven Therapeutics
―
AbCellera Biologics
―
LENZ Therapeutics
―
Ownership Overview
― Insiders
0.07% Mutual Funds
<0.01% Other Institutional Investors
98.34% Public Companies and
Individual Investors